MiR-4291 stabilized the vulnerable atherosclerotic plaques by degrading the MAPK1/ERK2 in ApoE-/- mice

被引:0
|
作者
Jin, Yaqiong [1 ]
Lu, Jingchao [1 ,2 ]
Liu, Fan [1 ]
Yang, Xiuchun [1 ]
Chen, Fei [1 ]
Zhang, Jie [1 ]
机构
[1] Hebei Med Univ, Dept Cardiol, Hosp 2, Shijiazhuang, Peoples R China
[2] Hebei Med Univ, Dept Cardiol, Hosp 2, Shijiazhuang, Hebei, Peoples R China
关键词
miR-4291; p-ERK1-2; fibrous cap thickness; vulnerable plaques; MIR-214; PATHWAY; DISEASE; TARGET;
D O I
10.21037/atm-22-5241
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: This study sought to explore the mechanism of action of the micro ribonucleic acid (miR)-4291 in stabilizing atherosclerotic (AS) plaques.Methods: An AS model of apolipoprotein E-deficient (ApoE-/-) mice fed a high-fat diet (HFD) was established. Oxidized low-density lipoprotein (ox-LDL) was used to induce an inflammatory response of RAW264.7 macrophages. The mice were divided into the normal diet (ND) + miR-4291 negative control (NC) group, the ND + miR-4291 mimic group, the HFD + miR-4291 NC group, and the HFD + miR-4291 mimic group. They were also classified into the miR-4291 NC group, the miR-4291 mimic group, the ox-LDL + miR-4291 NC group, and the ox-LDL + miR-4291 mimic group. The arterial plaque burden of the mice was assessed by hematoxylin-eosin staining and immunohistochemistry, and the expression of phosphorylated-extracellular signal-regulated kinase 2 (p-ERK2) and related proteins in the arterial plaques and RAW264.7 macrophages of the mice were detected by Western blotting.Results: Obvious plaques with massive macrophage infiltration were found in the aortic roots of the mice fed a HFD, and smooth muscle cells were found at the margin of the plaques. In the HFD + miR-4291 mimic group, the number of plaques and macrophages was significantly declined, but there were no significant changes in the smooth muscle cells compared to those in the HFD + miR-4291 NC group. The Western blot results showed that miR-4291 reduced the protein expression of p-ERK1-2, t-ERK1-2, TNF-alpha, MCP-1, MMP-1, MMP-3, and MMP-9 in the AS plaques and the ox-LDL-induced RAW264.7 macrophages of the mice fed a HFD.Conclusions: MiR-4291 reduced the expression of MMP-2/9 by inhibiting the activity of ERK2, which in turn increased the fibrous cap thickness and stabilized the vulnerable plaques in AS.
引用
收藏
页数:13
相关论文
共 42 条
  • [1] AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
    Furukawa, Toru
    Horii, Akira
    CANCER RESEARCH, 2006, 66 (08)
  • [2] AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
    T Furukawa
    N Kanai
    H O Shiwaku
    N Soga
    A Uehara
    A Horii
    Oncogene, 2006, 25 : 4831 - 4839
  • [3] AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
    Furukawa, T.
    Kanai, N.
    Shiwaku, H. O.
    Soga, N.
    Uehara, A.
    Horii, A.
    ONCOGENE, 2006, 25 (35) : 4831 - 4839
  • [4] Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense Mutants
    Brenan, Lisa
    Andreev, Aleksandr
    Cohen, Ofir
    Pantel, Sasha
    Kamburov, Atanas
    Cacchiarelli, Davide
    Persky, Nicole S.
    Zhu, Cong
    Bagul, Mukta
    Goetz, Eva M.
    Burgin, Alex B.
    Garraway, Levi A.
    Getz, Gad
    Mikkelsen, Tarjei S.
    Piccioni, Federica
    Root, David E.
    Johannessen, Cory M.
    CELL REPORTS, 2016, 17 (04): : 1171 - 1183
  • [5] Arginase inhibition prevents the low shear stress-induced development of vulnerable atherosclerotic plaques in ApoE-/- mice
    Olivon, Vania C.
    Fraga-Silva, Rodrigo A.
    Segers, Dolf
    Demougeot, Celine
    de Oliveira, Ana M.
    Savergnini, Silvia S.
    Berthelot, Alain
    de Crom, Rini
    Krams, Rob
    Stergiopulos, Nikos
    da Silva, Rafaela F.
    ATHEROSCLEROSIS, 2013, 227 (02) : 236 - 243
  • [6] miR-1 modulates HDAC4, calmodulin and MAPK1/Erk2 during early atrial differentiation
    Franco, D.
    Garcia-Padilla, C.
    Lozano-Velasco, E.
    Garcia-Lopez, V
    Aranega, A.
    Garcia-Martinez, V
    Lopez-Sanchez, C.
    CARDIOVASCULAR RESEARCH, 2024, 120
  • [7] Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma
    Chakraborty, Rikhia
    Hampton, Oliver A.
    Abhyankar, Harshal
    Zinn, Daniel J.
    Grimes, Amanda
    Skull, Brooks
    Eckstein, Olive
    Mahmood, Nadia
    Wheeler, David A.
    Lopez-Terrada, Dolores
    Peters, Tricia L.
    Hicks, John M.
    Elghetany, Tarek
    Krance, Robert
    Poulikakos, Poulikos I.
    Merad, Miriam
    McClain, Kenneth L.
    Allen, Carl E.
    Parsons, Donald W.
    ONCOTARGET, 2017, 8 (28) : 46065 - 46070
  • [8] Specific Targeting of Atherosclerotic Plaques in ApoE-/- Mice Using a New Camelid sdAb Binding the Vulnerable Plaque Marker LOX-1
    De Vos, Jens
    Mathijs, Iris
    Xavier, Catarina
    Massa, Sam
    Wernery, Ulrich
    Bouwens, Luc
    Lahoutte, Tony
    Muyldermans, Serge
    Devoogdt, Nick
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (05) : 690 - 698
  • [9] MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients
    Reyes-Gibby, Cielito C.
    Wang, Jian
    Silvas, Mary Rose T.
    Yu, Robert
    Yeung, Sai-Ching J.
    Shete, Sanjay
    BMC GENETICS, 2016, 17
  • [10] MAPK1/ERK2 as novel target genes for pain in head and neck cancer patients
    Cielito C. Reyes-Gibby
    Jian Wang
    Mary Rose T. Silvas
    Robert Yu
    Sai-Ching J. Yeung
    Sanjay Shete
    BMC Genetics, 17